Stay updated on CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial page.

Latest updates to the CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new information about the study of CT-P13, specifically highlighting its biological formulation and the study's EudraCT number. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference17%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial page.